RASA2 and neuroblastoma: Furthermore, expression of the gene for the Ras GTPase-activating protein (RasGAP) NF1 is also associated with neuroblastoma patient outcomes [27, 28], suggesting a more significant role for the RAS/MAPK pathway in neuroblastoma pathogenesis and disease relapse.